Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Venadaparib |
Synonyms | |
Therapy Description |
Venadaparib (IDX-1197) is a selective PARP inhibitor that inhibits DNA repair and may lead to tumor inhibition (Mol Cancer Ther 2018;17(1 Suppl):Abstract nr A106). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Venadaparib | IDX-1197|IDX1197|IDX 1197 | PARP Inhibitor (Pan) 31 | Venadaparib (IDX-1197) is a selective PARP inhibitor that inhibits DNA repair and may lead to tumor inhibition (Mol Cancer Ther 2018;17(1 Suppl):Abstract nr A106). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|